June 12, 2024
The American College of Radiology ® (ACR®) submitted comments June 6, in response to the fiscal year (FY) 2025 Hospital Inpatient Prospective Payment System (IPPS) proposed rule. The Centers for Medicare and Medicaid Services (CMS) requested stakeholder feedback on determining newness for technologies that use artificial intelligence (AI) software for New Technology Add-on Payments (NTAP).

ACR urged CMS to consider establishing a distinct, high-value AI-specific alternative NTAP pathway that would determine uniqueness based on whether the technology enables a clinically valuable task for Medicare beneficiaries not previously achievable without technology. The U.S. Food and Drug Administration currently is not required to consider a product’s value to the Medicare population as part of the Breakthrough Device designation. The College believes that value should not only be considered, but guided by input from physician experts and specialty communities for ongoing evaluations.

If you have questions, please contact Kimberly Greck, ACR Senior Economic Policy Analyst.

Related ACR News

  • ACR Recommends US Visa Flexibility for Healthcare Workers

    ACR urges DHS to implement flexibility for healthcare workers, streamline extensions, expand Conrad 30, and collaborate with the medical community.

    Read more
  • New Resource Empowers ACR Members to Shape Medicare Policy

    ACR’s CAC Network empowers members to help shape Medicare policy, boost radiology’s voice, and advance patient care through national advocacy.

    Read more
  • ACR Supports Radiation Oncology Case Rate (ROCR) Legislation

    ACR reaffirmed support for ROCR (H.R.2120/S.1031) to protect access to high quality radiation therapy cancer services.

    Read more